Literature DB >> 1503820

HIV drug resistance.

D D Richman1.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1503820     DOI: 10.1089/aid.1992.8.1065

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  18 in total

1.  Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.

Authors:  A Samri; G Haas; J Duntze; J M Bouley; V Calvez; C Katlama; B Autran
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.

Authors:  S Palmer; J Harmenberg; S Cox
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Community HIV-1 drug resistance is associated with transmitted drug resistance.

Authors:  M W Tilghman; J Pérez-Santiago; G Osorio; S J Little; D D Richman; W C Mathews; R H Haubrich; D M Smith
Journal:  HIV Med       Date:  2014-01-12       Impact factor: 3.180

4.  Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.

Authors:  R F Schinazi; R Sijbesma; G Srdanov; C L Hill; F Wudl
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 5.  Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.

Authors:  D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.

Authors:  R F Schinazi; R M Lloyd; M H Nguyen; D L Cannon; A McMillan; N Ilksoy; C K Chu; D C Liotta; H Z Bazmi; J W Mellors
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 7.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.

Authors:  L M Frenkel; L E Wagner; S M Atwood; T J Cummins; S Dewhurst
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  L F Rezende; W C Drosopoulos; V R Prasad
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.